BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy3914
(852 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 64/284 (22%), Positives = 116/284 (40%), Gaps = 53/284 (18%)
Query: 48 RDASKDFAYEVGEPAVSFSGCFTQKHTFWKFHGGKKKGSNEKVTIFLNDSADTYEPALSY 107
RDA+ D+ G+ V G +F + GK G + LN +A T + ++
Sbjct: 13 RDAADDWEIPDGQITV---GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAF 67
Query: 108 ---VKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYIS 164
V L+ RH +IL F+ +P ++V E +++HL + + KK I I+
Sbjct: 68 KNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEG-SSLYHHLHASETKFEMKKLIDIA 126
Query: 165 WGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLG------------GLEYMEKI 212
Q R + +L + + H + +IF++ K+G G E++
Sbjct: 127 ---RQTARGMDYL-HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182
Query: 213 SEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQSTN---- 268
S + R +D + Y +D+Y GI+++E+ G L +N
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSF-----------QSDVYAFGIVLYELMTGQLPYSNINNR 231
Query: 269 --------RKSLSN-----IDNIPENLKRVYLELISERPNQRPN 299
R SLS N P+ +KR+ E + ++ ++RP+
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 46/199 (23%), Positives = 83/199 (41%), Gaps = 28/199 (14%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 66 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 119
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC-IPMKRYSRYEDQS 230
ALS+ + + H + ++ + S GE K+ + SC P R +
Sbjct: 120 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SCHAPSSRRTTLSGTL 171
Query: 231 TYQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIP 279
Y PE + D++ LG+L +E G P ++ K +S + D +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 231
Query: 280 ENLKRVYLELISERPNQRP 298
E + + L+ P+QRP
Sbjct: 232 EGARDLISRLLKHNPSQRP 250
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 64/284 (22%), Positives = 115/284 (40%), Gaps = 53/284 (18%)
Query: 48 RDASKDFAYEVGEPAVSFSGCFTQKHTFWKFHGGKKKGSNEKVTIFLNDSADTYEPALSY 107
RD+S D+ G+ V G +F + GK G + LN +A T + ++
Sbjct: 13 RDSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAF 67
Query: 108 ---VKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYIS 164
V L+ RH +IL F+ P ++V E +++HL + + KK I I+
Sbjct: 68 KNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEG-SSLYHHLHASETKFEMKKLIDIA 126
Query: 165 WGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLG------------GLEYMEKI 212
Q R + +L + + H + +IF++ K+G G E++
Sbjct: 127 ---RQTARGMDYL-HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182
Query: 213 SEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQSTN---- 268
S + R +D + Y +D+Y GI+++E+ G L +N
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSF-----------QSDVYAFGIVLYELMTGQLPYSNINNR 231
Query: 269 --------RKSLSN-----IDNIPENLKRVYLELISERPNQRPN 299
R SLS N P+ +KR+ E + ++ ++RP+
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 64/284 (22%), Positives = 115/284 (40%), Gaps = 53/284 (18%)
Query: 48 RDASKDFAYEVGEPAVSFSGCFTQKHTFWKFHGGKKKGSNEKVTIFLNDSADTYEPALSY 107
RD+S D+ G+ V G +F + GK G + LN +A T + ++
Sbjct: 1 RDSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAF 55
Query: 108 ---VKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYIS 164
V L+ RH +IL F+ P ++V E +++HL + + KK I I+
Sbjct: 56 KNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEG-SSLYHHLHASETKFEMKKLIDIA 114
Query: 165 WGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLG------------GLEYMEKI 212
Q R + +L + + H + +IF++ K+G G E++
Sbjct: 115 ---RQTARGMDYL-HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQL 170
Query: 213 SEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQSTN---- 268
S + R +D + Y +D+Y GI+++E+ G L +N
Sbjct: 171 SGSILWMAPEVIRMQDSNPYSF-----------QSDVYAFGIVLYELMTGQLPYSNINNR 219
Query: 269 --------RKSLS-----NIDNIPENLKRVYLELISERPNQRPN 299
R SLS N P+ +KR+ E + ++ ++RP+
Sbjct: 220 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 263
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 43.9 bits (102), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL +F H+D LK+ + +
Sbjct: 52 AIREISLLKELNHPNIVKLLDVIHTENK--LYL-------VFEHVDQDLKKFMDASALTG 102
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 103 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 157
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 158 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 210
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 211 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 43.5 bits (101), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 113 TLRHPSILTFLDS--VESPSKSLVYLAVEYVEPI-FYHLDNTLKENNEKKQIYISWGIFQ 169
L HP+I+ D+ E+P+ L Y+ +EYV+ + + +T K+ I + I
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 124
Query: 170 ITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQ 229
+AL+F + + H V +I I++ K+ I++ S + + +
Sbjct: 125 ACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAAVIGT 182
Query: 230 STYQIPENSLSHVTKCSTDMYGLGILIWEVFNG 262
+ Y PE + +D+Y LG +++EV G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 113 TLRHPSILTFLDS--VESPSKSLVYLAVEYVEPI-FYHLDNTLKENNEKKQIYISWGIFQ 169
L HP+I+ D+ E+P+ L Y+ +EYV+ + + +T K+ I + I
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 124
Query: 170 ITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQ 229
+AL+F + + H V +I I++ K+ I++ S + + +
Sbjct: 125 ACQALNFSHQNG-IIHRDVKPANILISATNAVKVVDFGIARAIAD-SGNSVXQTAAVIGT 182
Query: 230 STYQIPENSLSHVTKCSTDMYGLGILIWEVFNG 262
+ Y PE + +D+Y LG +++EV G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 113 TLRHPSILTFLDS--VESPSKSLVYLAVEYVEPI-FYHLDNTLKENNEKKQIYISWGIFQ 169
L HP+I+ D+ E+P+ L Y+ +EYV+ + + +T K+ I + I
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 124
Query: 170 ITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQ 229
+AL+F + + H V +I I++ K+ I++ S + + +
Sbjct: 125 ACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAAVIGT 182
Query: 230 STYQIPENSLSHVTKCSTDMYGLGILIWEVFNG 262
+ Y PE + +D+Y LG +++EV G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 113 TLRHPSILTFLDS--VESPSKSLVYLAVEYVEPI-FYHLDNTLKENNEKKQIYISWGIFQ 169
L HP+I+ D+ E+P+ L Y+ +EYV+ + + +T K+ I + I
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 124
Query: 170 ITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQ 229
+AL+F + + H V +I I++ K+ I++ S + + +
Sbjct: 125 ACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAAVIGT 182
Query: 230 STYQIPENSLSHVTKCSTDMYGLGILIWEVFNG 262
+ Y PE + +D+Y LG +++EV G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 113 TLRHPSILTFLDS--VESPSKSLVYLAVEYVEPI-FYHLDNTLKENNEKKQIYISWGIFQ 169
L HP+I+ D+ E+P+ L Y+ +EYV+ + + +T K+ I + I
Sbjct: 85 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 141
Query: 170 ITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQ 229
+AL+F + + H V +I I++ K+ I++ S + + +
Sbjct: 142 ACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAAVIGT 199
Query: 230 STYQIPENSLSHVTKCSTDMYGLGILIWEVFNG 262
+ Y PE + +D+Y LG +++EV G
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 65 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 118
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 119 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTXLCGTLD 171
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 232 GARDLISRLLKHNPSQRP 249
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 37/160 (23%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYI 163
A+ + LK L HP+I++ +D + S+ + L E++E + + K + QI I
Sbjct: 66 AIREISLLKELHHPNIVSLIDVIH--SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI 123
Query: 164 SWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRY 223
++Q+ R ++ + + H + ++ INS G KL ++ A IP++ Y
Sbjct: 124 Y--LYQLLRGVAH-CHQHRILHRDLKPQNLLINSDGALKLADF----GLARAFGIPVRSY 176
Query: 224 SRYEDQSTYQIPENSL-SHVTKCSTDMYGLGILIWEVFNG 262
+ Y+ P+ + S S D++ +G + E+ G
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 69 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 122
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 123 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTTLCGTLD 175
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 235
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 236 GARDLISRLLKHNPSQRP 253
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 65 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 118
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 119 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRAALCGTLD 171
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 232 GARDLISRLLKHNPSQRP 249
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 65 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 118
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 119 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTELCGTLD 171
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 232 GARDLISRLLKHNPSQRP 249
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 68 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 121
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 122 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRAALCGTLD 174
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 235 GARDLISRLLKHNPSQRP 252
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENN---EKKQ 160
A+ + LK L HP+I++ +D + S+ + L E++E L L EN + Q
Sbjct: 66 AIREISLLKELHHPNIVSLIDVIH--SERCLTLVFEFMEK---DLKKVLDENKTGLQDSQ 120
Query: 161 IYISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPM 220
I I ++Q+ R ++ + + H + ++ INS G KL ++ A IP+
Sbjct: 121 IKIY--LYQLLRGVAH-CHQHRILHRDLKPQNLLINSDGALKLADF----GLARAFGIPV 173
Query: 221 KRYSRYEDQSTYQIPENSL-SHVTKCSTDMYGLGILIWEVFNG 262
+ Y+ Y+ P+ + S S D++ +G + E+ G
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 42.0 bits (97), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 65 LRHPNILRLYGYFHDSTR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 118
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 119 NALSY-CHSKKVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRAALCGTLD 171
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTE 231
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 232 GARDLISRLLKHNPSQRP 249
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 64 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 117
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 118 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTTLCGTLD 170
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 171 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 230
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 231 GARDLISRLLKHNPSQRP 248
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 70 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 123
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 124 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTTLCGTLD 176
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 237 GARDLISRLLKHNPSQRP 254
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 62 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 115
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 116 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTTLCGTLD 168
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 228
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 229 GARDLISRLLKHNPSQRP 246
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 65 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 118
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 119 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTTLCGTLD 171
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 232 GARDLISRLLKHNPSQRP 249
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 68 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 121
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 122 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIANFGW------SVHAPSSRRTTLCGTLD 174
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 235 GARDLISRLLKHNPSQRP 252
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 68 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 121
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 122 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTTLCGTLD 174
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 235 GARDLISRLLKHNPSQRP 252
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 67 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 120
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 121 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIANFGW------SVHAPSSRRTTLCGTLD 173
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 233
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 234 GARDLISRLLKHNPSQRP 251
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 65 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 118
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 119 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTDLCGTLD 171
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 232 GARDLISRLLKHNPSQRP 249
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 68 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 121
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 122 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTTLCGTLD 174
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 235 GARDLISRLLKHNPSQRP 252
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 66 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 119
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 120 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTDLCGTLD 172
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 232
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 233 GARDLISRLLKHNPSQRP 250
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 70 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 123
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 124 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTDLCGTLD 176
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 237 GARDLISRLLKHNPSQRP 254
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 65 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 118
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R
Sbjct: 119 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRXXLCGTLD 171
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 232 GARDLISRLLKHNPSQRP 249
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 49 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 99
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + LSF + + H + ++ IN+ G KL ++ A
Sbjct: 100 IPLPLIKSYLFQLLQGLSF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 154
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 155 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 207
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 208 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 65 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 118
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 119 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTDLCGTLD 171
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 232 GARDLISRLLKHNPSQRP 249
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 68 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 121
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R
Sbjct: 122 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRXXLCGTLD 174
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 235 GARDLISRLLKHNPSQRP 252
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 68 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 121
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R
Sbjct: 122 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRDDLCGTLD 174
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 235 GARDLISRLLKHNPSQRP 252
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 41.2 bits (95), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 91 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 144
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 145 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTTLCGTLD 197
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 257
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 258 GARDLISRLLKHNPSQRP 275
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 70 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 123
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 124 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTTLCGTLD 176
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE D++ LG+L +E G P ++ K +S + D + E
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 237 GARDLISRLLKHNPSQRP 254
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 82 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 135
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R +
Sbjct: 136 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRTTLCGTLD 188
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 248
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 249 GARDLISRLLKHNPSQRP 266
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 67 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 120
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R
Sbjct: 121 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRXXLCGTLD 173
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 233
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 234 GARDLISRLLKHNPSQRP 251
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 66 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 119
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R
Sbjct: 120 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRDTLCGTLD 172
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 232
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 233 GARDLISRLLKHNPSQRP 250
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLD-NTLKENNEKKQI- 161
A+ + LK L HP+I+ LD + + +K +YL E+V H D T + + I
Sbjct: 48 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFEHV-----HQDLKTFMDASALTGIP 100
Query: 162 --YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIP 219
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A +P
Sbjct: 101 LPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFGVP 155
Query: 220 MKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNIDNI 278
++ Y+ Y+ PE L + D++ LG + E+ R++L D+
Sbjct: 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGDSE 208
Query: 279 PENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ L R++ L + P++ P M + KP
Sbjct: 209 IDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 40.8 bits (94), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 44/239 (18%)
Query: 102 EPALSYVKKLKTLRHPSILTFLDS-VE-------SPSKSLVYLAVEYVEPIFYHLDNTLK 153
E + VK L L HP I+ + ++ +E PS VYL Y++ +N
Sbjct: 48 EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL---YIQMQLCRKENLKD 104
Query: 154 ENN-----EKKQIYISWGIF-QITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGG-- 205
N E+++ + IF QI A+ FL + L H + ++IF K+G
Sbjct: 105 WMNGRCTIEERERSVCLHIFLQIAEAVEFL-HSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163
Query: 206 -LEYMEKISEASCI--PMKRYSRYEDQ-------STYQIPENSLSHVTKCSTDMYGLGIL 255
+ M++ E + PM Y+R+ Q S QI NS SH D++ LG++
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH----KVDIFSLGLI 219
Query: 256 IWE-VFNGPLQSTNRKSLSNIDNI--PENLKRVY-------LELISERPNQRPNPADFI 304
++E ++ Q ++L+++ N+ P + Y +++S P +RP + I
Sbjct: 220 LFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 40.8 bits (94), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 56 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 106
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 107 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 161
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 162 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 214
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 215 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 246
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 56 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 106
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 107 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 161
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 162 VPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 214
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 215 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 246
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLD-NTLKENNEKKQI- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D T + + I
Sbjct: 52 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQDLKTFMDASALTGIP 104
Query: 162 --YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIP 219
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A +P
Sbjct: 105 LPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFGVP 159
Query: 220 MKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNIDNI 278
++ Y Y+ PE L + D++ LG + E+ R++L D+
Sbjct: 160 VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGDSE 212
Query: 279 PENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ L R++ L + P++ P M + KP
Sbjct: 213 IDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 49 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 99
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 100 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 154
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 155 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 207
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 208 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 48 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 98
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 99 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 153
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 206
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 207 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 49 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 99
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 100 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 154
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 155 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 207
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 208 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 49 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 99
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 100 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 154
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 155 VPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 207
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 208 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 50 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 100
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 101 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 155
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 156 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 208
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 209 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 240
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 26/198 (13%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEY--VEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
LRHP+IL ++ VYL +EY + ++ L K + ++ YI+ ++
Sbjct: 91 LRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELA 144
Query: 172 RALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQST 231
ALS+ + + H + ++ + S GE K+ + + P R
Sbjct: 145 NALSY-CHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSRRDDLCGTLD 197
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQST----NRKSLSNI-----DNIPE 280
Y PE + D++ LG+L +E G P ++ K +S + D + E
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 257
Query: 281 NLKRVYLELISERPNQRP 298
+ + L+ P+QRP
Sbjct: 258 GARDLISRLLKHNPSQRP 275
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 40.4 bits (93), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 48 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 98
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 99 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 153
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 206
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 207 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 40.4 bits (93), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 53 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 103
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 104 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 158
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 159 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 211
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 212 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 243
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 40.0 bits (92), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 49 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 99
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 100 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 154
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 155 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 207
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 208 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 40.0 bits (92), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 48 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 98
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 99 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 153
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y+ Y+ PE L + D++ LG + E+ R++L D
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 206
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 207 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 40.0 bits (92), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/198 (18%), Positives = 86/198 (43%), Gaps = 26/198 (13%)
Query: 74 TFWKFHGGKKKGSNEKVTIFLNDS--ADTYEPALSYVKKLKTLRHPSILTFLDSVESPSK 131
+F H + GS+ V I + A+ L V +K LRHP+I+ F+ +V P
Sbjct: 49 SFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108
Query: 132 SLVYLAVEYVEP----IFYHLDNTLKENNEKKQIYISWGIFQITRALSFLIN-DADLRHN 186
+ + EY+ H ++ +E++++ ++ + + + +++L N + + H
Sbjct: 109 --LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA---YDVAKGMNYLHNRNPPIVHR 163
Query: 187 HVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQSTYQIPENSLSHVTKC- 245
++ ++ ++ +Y K+ + +K + +S PE V +
Sbjct: 164 NLKSPNLLVDK---------KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 246 ----STDMYGLGILIWEV 259
+D+Y G+++WE+
Sbjct: 215 PSNEKSDVYSFGVILWEL 232
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 40.0 bits (92), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 35/153 (22%), Positives = 68/153 (44%), Gaps = 8/153 (5%)
Query: 113 TLRHPSILTFLDS--VESPSKSLVYLAVEYVEPI-FYHLDNTLKENNEKKQIYISWGIFQ 169
L HP+I+ + E+P+ L Y+ +EYV+ + + +T K+ I + I
Sbjct: 68 ALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 124
Query: 170 ITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQ 229
+AL+F + + H V +I I++ K+ I++ S + + +
Sbjct: 125 ACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAAVIGT 182
Query: 230 STYQIPENSLSHVTKCSTDMYGLGILIWEVFNG 262
+ Y PE + +D+Y LG +++EV G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 39.7 bits (91), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 49 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKDFMDASALTG 99
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 100 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPENLLINTEGAIKLADF----GLARAFG 154
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 155 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 207
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 208 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 39.7 bits (91), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 49/214 (22%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E+ L LK+ + +
Sbjct: 51 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFEF-------LSMDLKDFMDASALTG 101
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 102 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 156
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 157 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 209
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 210 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 241
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 39.7 bits (91), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 52 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 102
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 103 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 157
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 158 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 210
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 211 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 39.7 bits (91), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 52 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 102
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 103 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 157
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 158 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 210
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 211 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 39.7 bits (91), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 51 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 101
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 102 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 156
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 157 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 209
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 210 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 241
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 39.7 bits (91), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 53 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 103
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 104 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 158
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 159 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 211
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 212 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 243
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 39.7 bits (91), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 49 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 99
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 100 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 154
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 155 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 207
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 208 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 39.7 bits (91), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 50 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 100
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 101 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 155
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 156 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 208
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 209 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 240
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 39.7 bits (91), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 49 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 99
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 100 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 154
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 155 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 207
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 208 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 48 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 98
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 99 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 153
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 154 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 206
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 207 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 50 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 100
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 101 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 155
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 156 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 208
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 209 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 240
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 49 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 99
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 100 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 154
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 155 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 207
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 208 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 51 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 101
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 102 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 156
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 157 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 209
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 210 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 241
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 50 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 100
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 101 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPENLLINTEGAIKLADF----GLARAFG 155
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 156 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 208
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 209 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 240
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 39.3 bits (90), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 49 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 99
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 100 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 154
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 155 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 207
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 208 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 39.3 bits (90), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 49/214 (22%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E+ L LK+ + +
Sbjct: 52 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFEF-------LSMDLKDFMDASALTG 102
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 103 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 157
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 158 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 210
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 211 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 39.3 bits (90), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 48 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 98
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 99 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPQNLLINTEGAIKLADF----GLARAFG 153
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 154 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 206
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 207 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E F H D LK+ + +
Sbjct: 51 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFE-----FLHQD--LKKFMDASALTG 101
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 102 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPENLLINTEGAIKLADF----GLARAFG 156
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 157 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 209
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 210 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 241
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 49/214 (22%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E+ L LK+ + +
Sbjct: 50 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFEF-------LSMDLKKFMDASALTG 100
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 101 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPENLLINTEGAIKLADF----GLARAFG 155
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 156 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 208
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 209 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 240
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 39.3 bits (90), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 49/214 (22%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQI-- 161
A+ + LK L HP+I+ LD + + +K +YL E+ L LK+ + +
Sbjct: 52 AIREISLLKELNHPNIVKLLDVIHTENK--LYLVFEF-------LSMDLKKFMDASALTG 102
Query: 162 ----YISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASC 217
I +FQ+ + L+F + + H + ++ IN+ G KL ++ A
Sbjct: 103 IPLPLIKSYLFQLLQGLAF-CHSHRVLHRDLKPENLLINTEGAIKLADF----GLARAFG 157
Query: 218 IPMKRYSRYEDQSTYQIPENSLS-HVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNID 276
+P++ Y Y+ PE L + D++ LG + E+ R++L D
Sbjct: 158 VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM-------VTRRALFPGD 210
Query: 277 NIPENLKRVYLELISERPNQRPNPADFIMRNRKP 310
+ + L R++ L + P++ P M + KP
Sbjct: 211 SEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 37.0 bits (84), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 32/155 (20%), Positives = 62/155 (40%), Gaps = 28/155 (18%)
Query: 168 FQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYE 227
+QI++ + +L + L H + +I + + K+ + E Y
Sbjct: 157 WQISQGMQYL-AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS--------YV 207
Query: 228 DQSTYQIP------ENSLSHVTKCSTDMYGLGILIWEVF---NGPLQSTNRKSLSNI--- 275
+S +IP E+ H+ +D++ G+L+WE+ P + L N+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267
Query: 276 -------DNIPENLKRVYLELISERPNQRPNPADF 303
DN E + R+ L+ + P++RP AD
Sbjct: 268 GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 37.0 bits (84), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 36/198 (18%), Positives = 83/198 (41%), Gaps = 26/198 (13%)
Query: 74 TFWKFHGGKKKGSNEKVTIFLNDS--ADTYEPALSYVKKLKTLRHPSILTFLDSVESPSK 131
+F H + GS+ V I + A+ L V +K LRHP+I+ F+ +V P
Sbjct: 49 SFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108
Query: 132 SLVYLAVEYVEP----IFYHLDNTLKENNEKKQIYISWGIFQITRALSFLIN-DADLRHN 186
+ + EY+ H ++ +E++++ ++ + + + +++L N + + H
Sbjct: 109 --LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA---YDVAKGMNYLHNRNPPIVHR 163
Query: 187 HVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQSTYQIPENSLSHVTKC- 245
+ ++ ++ +Y K+ + +K + PE V +
Sbjct: 164 DLKSPNLLVDK---------KYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 246 ----STDMYGLGILIWEV 259
+D+Y G+++WE+
Sbjct: 215 PSNEKSDVYSFGVILWEL 232
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 37.0 bits (84), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 60/282 (21%), Positives = 110/282 (39%), Gaps = 51/282 (18%)
Query: 48 RDASKDFAYEVGEPAVSFSGCFTQKHTFWKFHGGKKKGSNEKVTIFLNDSADTYEPALSY 107
RD+S D+ G+ V G +F + GK G + LN +A T + ++
Sbjct: 24 RDSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAF 78
Query: 108 ---VKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYIS 164
V L+ RH +IL F+ P ++V E +++HL + K I I+
Sbjct: 79 KNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEG-SSLYHHLHIIETKFEMIKLIDIA 137
Query: 165 WGIFQITRALSFL----INDADLRHNHVNHTSIFINSCGEWKLG-------GLEYMEKIS 213
Q + + +L I DL+ N++ G++ L G E++S
Sbjct: 138 ---RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 194
Query: 214 EASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLS 273
+ R +D++ Y +D+Y GI+++E+ G L +N +
Sbjct: 195 GSILWMAPEVIRMQDKNPYSF-----------QSDVYAFGIVLYELMTGQLPYSNINNRD 243
Query: 274 NI-----------------DNIPENLKRVYLELISERPNQRP 298
I N P+ +KR+ E + ++ ++RP
Sbjct: 244 QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP 285
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 37.0 bits (84), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 60/282 (21%), Positives = 110/282 (39%), Gaps = 51/282 (18%)
Query: 48 RDASKDFAYEVGEPAVSFSGCFTQKHTFWKFHGGKKKGSNEKVTIFLNDSADTYEPALSY 107
RD+S D+ G+ V G +F + GK G + LN +A T + ++
Sbjct: 25 RDSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAF 79
Query: 108 ---VKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYIS 164
V L+ RH +IL F+ P ++V E +++HL + K I I+
Sbjct: 80 KNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEG-SSLYHHLHIIETKFEMIKLIDIA 138
Query: 165 WGIFQITRALSFL----INDADLRHNHVNHTSIFINSCGEWKLG-------GLEYMEKIS 213
Q + + +L I DL+ N++ G++ L G E++S
Sbjct: 139 ---RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 195
Query: 214 EASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLS 273
+ R +D++ Y +D+Y GI+++E+ G L +N +
Sbjct: 196 GSILWMAPEVIRMQDKNPYSF-----------QSDVYAFGIVLYELMTGQLPYSNINNRD 244
Query: 274 NI-----------------DNIPENLKRVYLELISERPNQRP 298
I N P+ +KR+ E + ++ ++RP
Sbjct: 245 QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP 286
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 37.0 bits (84), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 13/93 (13%)
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQS-------------TNRKSLSNIDNI 278
+ PE + +D++ G+++WEVF+ LQ NR+ L D+
Sbjct: 196 WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDC 255
Query: 279 PENLKRVYLELISERPNQRPNPADFIMRNRKPG 311
P + + +E +E P++RP D R R G
Sbjct: 256 PAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 37.0 bits (84), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 60/282 (21%), Positives = 110/282 (39%), Gaps = 51/282 (18%)
Query: 48 RDASKDFAYEVGEPAVSFSGCFTQKHTFWKFHGGKKKGSNEKVTIFLNDSADTYEPALSY 107
RD+S D+ G+ V G +F + GK G + LN +A T + ++
Sbjct: 25 RDSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAF 79
Query: 108 ---VKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYIS 164
V L+ RH +IL F+ P ++V E +++HL + K I I+
Sbjct: 80 KNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEG-SSLYHHLHIIETKFEMIKLIDIA 138
Query: 165 WGIFQITRALSFL----INDADLRHNHVNHTSIFINSCGEWKLG-------GLEYMEKIS 213
Q + + +L I DL+ N++ G++ L G E++S
Sbjct: 139 ---RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 195
Query: 214 EASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLS 273
+ R +D++ Y +D+Y GI+++E+ G L +N +
Sbjct: 196 GSILWMAPEVIRMQDKNPYSF-----------QSDVYAFGIVLYELMTGQLPYSNINNRD 244
Query: 274 NI-----------------DNIPENLKRVYLELISERPNQRP 298
I N P+ +KR+ E + ++ ++RP
Sbjct: 245 QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP 286
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 36.6 bits (83), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 60/282 (21%), Positives = 110/282 (39%), Gaps = 51/282 (18%)
Query: 48 RDASKDFAYEVGEPAVSFSGCFTQKHTFWKFHGGKKKGSNEKVTIFLNDSADTYEPALSY 107
RD+S D+ G+ V G +F + GK G + LN +A T + ++
Sbjct: 17 RDSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAF 71
Query: 108 ---VKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYIS 164
V L+ RH +IL F+ P ++V E +++HL + K I I+
Sbjct: 72 KNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEG-SSLYHHLHIIETKFEMIKLIDIA 130
Query: 165 WGIFQITRALSFL----INDADLRHNHVNHTSIFINSCGEWKLG-------GLEYMEKIS 213
Q + + +L I DL+ N++ G++ L G E++S
Sbjct: 131 ---RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 187
Query: 214 EASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLS 273
+ R +D++ Y +D+Y GI+++E+ G L +N +
Sbjct: 188 GSILWMAPEVIRMQDKNPYSF-----------QSDVYAFGIVLYELMTGQLPYSNINNRD 236
Query: 274 NI-----------------DNIPENLKRVYLELISERPNQRP 298
I N P+ +KR+ E + ++ ++RP
Sbjct: 237 QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP 278
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 36.6 bits (83), Expect = 0.060, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 13/93 (13%)
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQS-------------TNRKSLSNIDNI 278
+ PE + +D++ G+++WEVF+ LQ NR+ L D+
Sbjct: 213 WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDC 272
Query: 279 PENLKRVYLELISERPNQRPNPADFIMRNRKPG 311
P + + +E +E P++RP D R R G
Sbjct: 273 PAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 36.6 bits (83), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 60/283 (21%), Positives = 110/283 (38%), Gaps = 51/283 (18%)
Query: 47 GRDASKDFAYEVGEPAVSFSGCFTQKHTFWKFHGGKKKGSNEKVTIFLNDSADTYEPALS 106
G D+S D+ G+ V G +F + GK G + LN +A T + +
Sbjct: 1 GSDSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQA 55
Query: 107 Y---VKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYI 163
+ V L+ RH +IL F+ P ++V E +++HL + K I I
Sbjct: 56 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEG-SSLYHHLHIIETKFEMIKLIDI 114
Query: 164 SWGIFQITRALSFL----INDADLRHNHVNHTSIFINSCGEWKLG-------GLEYMEKI 212
+ Q + + +L I DL+ N++ G++ L G E++
Sbjct: 115 A---RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 213 SEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQSTNRKSL 272
S + R +D++ Y +D+Y GI+++E+ G L +N +
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSF-----------QSDVYAFGIVLYELMTGQLPYSNINNR 220
Query: 273 SNI-----------------DNIPENLKRVYLELISERPNQRP 298
I N P+ +KR+ E + ++ ++RP
Sbjct: 221 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP 263
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 36.6 bits (83), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 60/283 (21%), Positives = 110/283 (38%), Gaps = 51/283 (18%)
Query: 47 GRDASKDFAYEVGEPAVSFSGCFTQKHTFWKFHGGKKKGSNEKVTIFLNDSADTYEPALS 106
G D+S D+ G+ V G +F + GK G + LN +A T + +
Sbjct: 1 GSDSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQA 55
Query: 107 Y---VKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYI 163
+ V L+ RH +IL F+ P ++V E +++HL + K I I
Sbjct: 56 FKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEG-SSLYHHLHIIETKFEMIKLIDI 114
Query: 164 SWGIFQITRALSFL----INDADLRHNHVNHTSIFINSCGEWKLG-------GLEYMEKI 212
+ Q + + +L I DL+ N++ G++ L G E++
Sbjct: 115 A---RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 213 SEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQSTNRKSL 272
S + R +D++ Y +D+Y GI+++E+ G L +N +
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSF-----------QSDVYAFGIVLYELMTGQLPYSNINNR 220
Query: 273 SNI-----------------DNIPENLKRVYLELISERPNQRP 298
I N P+ +KR+ E + ++ ++RP
Sbjct: 221 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP 263
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 36.2 bits (82), Expect = 0.078, Method: Compositional matrix adjust.
Identities = 29/149 (19%), Positives = 60/149 (40%), Gaps = 16/149 (10%)
Query: 168 FQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYE 227
+QI++ + +L + L H + +I + + K+ + E + R
Sbjct: 157 WQISQGMQYL-AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIP 215
Query: 228 DQSTYQIPENSLSHVTKCSTDMYGLGILIWEVF---NGPLQSTNRKSLSNI--------- 275
+ + E+ H+ +D++ G+L+WE+ P + L N+
Sbjct: 216 VK--WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMER 273
Query: 276 -DNIPENLKRVYLELISERPNQRPNPADF 303
DN E + R+ L+ + P++RP AD
Sbjct: 274 PDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 36.2 bits (82), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 29/149 (19%), Positives = 60/149 (40%), Gaps = 16/149 (10%)
Query: 168 FQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYE 227
+QI++ + +L + L H + +I + + K+ + E + R
Sbjct: 157 WQISQGMQYL-AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIP 215
Query: 228 DQSTYQIPENSLSHVTKCSTDMYGLGILIWEVF---NGPLQSTNRKSLSNI--------- 275
+ + E+ H+ +D++ G+L+WE+ P + L N+
Sbjct: 216 VK--WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMER 273
Query: 276 -DNIPENLKRVYLELISERPNQRPNPADF 303
DN E + R+ L+ + P++RP AD
Sbjct: 274 PDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 36.2 bits (82), Expect = 0.085, Method: Compositional matrix adjust.
Identities = 32/166 (19%), Positives = 74/166 (44%), Gaps = 10/166 (6%)
Query: 108 VKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYISWGI 167
++ L+ LRH +++ +D + + K +Y+ +EY + +++ E ++ + + G
Sbjct: 57 IQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGY 114
Query: 168 F-QITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRY 226
F Q+ L +L + + H + ++ + + G K+ L E + + R S
Sbjct: 115 FCQLIDGLEYL-HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-- 171
Query: 227 EDQSTYQIPE--NSLSHVTKCSTDMYGLGILIWEVFNG--PLQSTN 268
+ +Q PE N L + D++ G+ ++ + G P + N
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 34.7 bits (78), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 32/165 (19%), Positives = 73/165 (44%), Gaps = 18/165 (10%)
Query: 105 LSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYIS 164
+S V L+ L+HP+I+ + D + + + +Y+ +EY E L + + + +++Q
Sbjct: 53 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG--GDLASVITKGTKERQYLDE 110
Query: 165 WGIFQITRALSFLINDADLR--------HNHVNHTSIFINSCGEWKLGGLEYMEKISEAS 216
+ ++ L+ + + R H + ++F++ KLG ++ +
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 217 CIPMKRYSRYEDQSTYQIPE--NSLSHVTKCSTDMYGLGILIWEV 259
+ Y PE N +S+ K +D++ LG L++E+
Sbjct: 171 SFA----KAFVGTPYYMSPEQMNRMSYNEK--SDIWSLGCLLYEL 209
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 34.7 bits (78), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 32/165 (19%), Positives = 73/165 (44%), Gaps = 18/165 (10%)
Query: 105 LSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYIS 164
+S V L+ L+HP+I+ + D + + + +Y+ +EY E L + + + +++Q
Sbjct: 53 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG--GDLASVITKGTKERQYLDE 110
Query: 165 WGIFQITRALSFLINDADLR--------HNHVNHTSIFINSCGEWKLGGLEYMEKISEAS 216
+ ++ L+ + + R H + ++F++ KLG ++ +
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 217 CIPMKRYSRYEDQSTYQIPE--NSLSHVTKCSTDMYGLGILIWEV 259
+ Y PE N +S+ K +D++ LG L++E+
Sbjct: 171 SFA----KTFVGTPYYMSPEQMNRMSYNEK--SDIWSLGCLLYEL 209
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 34.7 bits (78), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 51/248 (20%), Positives = 97/248 (39%), Gaps = 46/248 (18%)
Query: 82 KKKGSNEKVTIFLNDSADTYEPALSY---VKKLKTLRHPSILTFLDSVESPSKSLVYLAV 138
K K + LN +A T + ++ V L+ RH +IL F+ +P ++V
Sbjct: 26 KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85
Query: 139 EYVEPIFYHLDNTLKENNEKKQIYISWGIFQITRALSFL----INDADLRHNHVNHTSIF 194
E +++HL + K I I+ Q + + +L I DL+ N++
Sbjct: 86 EG-SSLYHHLHIIETKFEMIKLIDIA---RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 141
Query: 195 INSCGEWKLG-------GLEYMEKISEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCST 247
G++ L G E++S + R +D++ Y +
Sbjct: 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF-----------QS 190
Query: 248 DMYGLGILIWEVFNGPLQSTNRKSLSNI-----------------DNIPENLKRVYLELI 290
D+Y GI+++E+ G L +N + I N P+ +KR+ E +
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250
Query: 291 SERPNQRP 298
++ ++RP
Sbjct: 251 KKKRDERP 258
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 34.3 bits (77), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 22/176 (12%)
Query: 111 LKTLRHPSILTFLDSVESPSKSLVYLAVEYVE--PIFYHLDNTLKENNEKKQIYISWGIF 168
L RH +IL +S ES + + + E++ IF ++ + E NE++ I +
Sbjct: 55 LNIARHRNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNERE---IVSYVH 109
Query: 169 QITRALSFL----INDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYS 224
Q+ AL FL I D+R ++ + + ++ + G ++ P +
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--------PGDNFR 161
Query: 225 RYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGP---LQSTNRKSLSNIDN 277
Y PE V +TDM+ LG L++ + +G L TN++ + NI N
Sbjct: 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 34.3 bits (77), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 26/158 (16%)
Query: 114 LRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYISWGIFQITRA 173
L H +I++ +D E YL +EY+E TL E E S G + A
Sbjct: 68 LSHQNIVSMIDVDEE--DDCYYLVMEYIEG------PTLSEYIE------SHGPLSVDTA 113
Query: 174 LSFL---------INDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYS 224
++F +D + H + +I I+S K+ + +SE S + + +
Sbjct: 114 INFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS---LTQTN 170
Query: 225 RYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNG 262
Y PE + T TD+Y +GI+++E+ G
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 33.9 bits (76), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 51/248 (20%), Positives = 96/248 (38%), Gaps = 46/248 (18%)
Query: 82 KKKGSNEKVTIFLNDSADTYEPALSY---VKKLKTLRHPSILTFLDSVESPSKSLVYLAV 138
K K + LN +A T + ++ V L+ RH +IL F+ P ++V
Sbjct: 26 KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWC 85
Query: 139 EYVEPIFYHLDNTLKENNEKKQIYISWGIFQITRALSFL----INDADLRHNHVNHTSIF 194
E +++HL + K I I+ Q + + +L I DL+ N++
Sbjct: 86 EG-SSLYHHLHIIETKFEMIKLIDIA---RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 141
Query: 195 INSCGEWKLG-------GLEYMEKISEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCST 247
G++ L G E++S + R +D++ Y +
Sbjct: 142 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF-----------QS 190
Query: 248 DMYGLGILIWEVFNGPLQSTNRKSLSNI-----------------DNIPENLKRVYLELI 290
D+Y GI+++E+ G L +N + I N P+ +KR+ E +
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250
Query: 291 SERPNQRP 298
++ ++RP
Sbjct: 251 KKKRDERP 258
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 33.5 bits (75), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 51/248 (20%), Positives = 96/248 (38%), Gaps = 46/248 (18%)
Query: 82 KKKGSNEKVTIFLNDSADTYEPALSY---VKKLKTLRHPSILTFLDSVESPSKSLVYLAV 138
K K + LN +A T + ++ V L+ RH +IL F+ P ++V
Sbjct: 28 KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWC 87
Query: 139 EYVEPIFYHLDNTLKENNEKKQIYISWGIFQITRALSFL----INDADLRHNHVNHTSIF 194
E +++HL + K I I+ Q + + +L I DL+ N++
Sbjct: 88 EG-SSLYHHLHIIETKFEMIKLIDIA---RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 143
Query: 195 INSCGEWKLG-------GLEYMEKISEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCST 247
G++ L G E++S + R +D++ Y +
Sbjct: 144 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF-----------QS 192
Query: 248 DMYGLGILIWEVFNGPLQSTNRKSLSNI-----------------DNIPENLKRVYLELI 290
D+Y GI+++E+ G L +N + I N P+ +KR+ E +
Sbjct: 193 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 252
Query: 291 SERPNQRP 298
++ ++RP
Sbjct: 253 KKKRDERP 260
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 33.5 bits (75), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 51/248 (20%), Positives = 96/248 (38%), Gaps = 46/248 (18%)
Query: 82 KKKGSNEKVTIFLNDSADTYEPALSY---VKKLKTLRHPSILTFLDSVESPSKSLVYLAV 138
K K + LN +A T + ++ V L+ RH +IL F+ P ++V
Sbjct: 26 KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWC 85
Query: 139 EYVEPIFYHLDNTLKENNEKKQIYISWGIFQITRALSFL----INDADLRHNHVNHTSIF 194
E +++HL + K I I+ Q + + +L I DL+ N++
Sbjct: 86 EG-SSLYHHLHIIETKFEMIKLIDIA---RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 141
Query: 195 INSCGEWKLG-------GLEYMEKISEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCST 247
G++ L G E++S + R +D++ Y +
Sbjct: 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF-----------QS 190
Query: 248 DMYGLGILIWEVFNGPLQSTNRKSLSNI-----------------DNIPENLKRVYLELI 290
D+Y GI+++E+ G L +N + I N P+ +KR+ E +
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250
Query: 291 SERPNQRP 298
++ ++RP
Sbjct: 251 KKKRDERP 258
>pdb|2X1G|F Chain F, Crystal Structure Of Importin13 - Mago-Y14 Complex
pdb|2X1G|G Chain G, Crystal Structure Of Importin13 - Mago-Y14 Complex
Length = 971
Score = 33.5 bits (75), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 52/238 (21%), Positives = 95/238 (39%), Gaps = 33/238 (13%)
Query: 390 EDYQAKIVPCVVKLFGSNDRATRSRLLLQL----EHFIGHVPDAI--------------V 431
E+ + KI+ +V+ F + +RL + L H +G P AI V
Sbjct: 81 EELKQKILESIVR-FAGGPKIVLNRLCISLGAYIVHMLGEWPGAIEEVINTFQNQRMPNV 139
Query: 432 NEQIFQQVALGFLDTNP---TIREQTVKSIIHLAPKLNYNNLNVETLRHFARLQAK---D 485
+ + + L L P + +VK ++ A L + T+ + +LQ D
Sbjct: 140 SADVQLWIMLEVLTAIPEEAQVIHTSVKRVVLRAEIAKRVQLVIHTVERYLKLQMNRVWD 199
Query: 486 DQGGIRTNTTV-CVGKIAHHLHPQIRQKVLISA-FSRAMRDPFPPARNAGVLALAATQQY 543
+ N V CVG ++ I V I+A + + P +AG + A +
Sbjct: 200 AEAYSNMNRAVKCVGTWIKNIGYTIEGCVTITAVLLEVVHKCYWPCIHAGDGCMTADE-- 257
Query: 544 FLLSEVAQRILPALCQLSTDPE-KSVRDSAFKTIKGFLGKLEQVSENPSLRESMEADV 600
+E+A+ L + + P+ + +AF IK FL L ++++ RE+ D+
Sbjct: 258 ---NELAESCLKTMVNIIIQPDCHNYPKTAFVLIKMFLDSLSEITKTEWKRENDNEDI 312
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 33.5 bits (75), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 32/165 (19%), Positives = 72/165 (43%), Gaps = 18/165 (10%)
Query: 105 LSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYIS 164
+S V L+ L+HP+I+ + D + + + +Y+ +EY E L + + + +++Q
Sbjct: 53 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG--GDLASVITKGTKERQYLDE 110
Query: 165 WGIFQITRALSFLINDADLR--------HNHVNHTSIFINSCGEWKLGGLEYMEKISEAS 216
+ ++ L+ + + R H + ++F++ KLG ++
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE 170
Query: 217 CIPMKRYSRYEDQSTYQIPE--NSLSHVTKCSTDMYGLGILIWEV 259
+ Y PE N +S+ K +D++ LG L++E+
Sbjct: 171 DFA----KEFVGTPYYMSPEQMNRMSYNEK--SDIWSLGCLLYEL 209
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 33.5 bits (75), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 53/269 (19%), Positives = 102/269 (37%), Gaps = 35/269 (13%)
Query: 53 DFAYEVGEPAVSFSGCFTQKHTFWKFHGGKKKGSNEKVTIFLNDSADTYEPALSYVKKLK 112
DFA E + G FW K + D + T E K
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPD---EDISQTIENVRQEAKLFA 61
Query: 113 TLRHPSILTFLD-SVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYISWGIFQIT 171
L+HP+I+ ++ P+ LV +E+ L+ L I ++W + QI
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLV---MEFARG--GPLNRVLSGKRIPPDILVNWAV-QIA 115
Query: 172 RALSFLINDA--DLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKR-YSRYED 228
R +++L ++A + H + ++I I K+ + KI + + + R + R
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQ----KVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 229 QST-----YQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQ-------------STNRK 270
S + PE + + +D++ G+L+WE+ G + + N+
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231
Query: 271 SLSNIDNIPENLKRVYLELISERPNQRPN 299
+L PE ++ + + P+ RP+
Sbjct: 232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPS 260
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 33.1 bits (74), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 42/220 (19%)
Query: 116 HPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENNEKKQIYISWGIFQITRALS 175
HP+I+ L+ V + SK V + EY+E LD LK+N+ + + G+ + A
Sbjct: 82 HPNII-HLEGVVTKSKP-VMIVTEYMEN--GSLDTFLKKNDGQFTVIQLVGMLRGISAGM 137
Query: 176 FLINDADLRHNHVNHTSIFINS---CGEWKLGGLEYMEKISEASC------IPMKRYSRY 226
++D H + +I INS C G +E EA+ IP++
Sbjct: 138 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR----- 192
Query: 227 EDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNGP----LQSTNRKSLSNID------ 276
+ PE ++D++ GI++WEV + + TN+ + ++
Sbjct: 193 -----WTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLP 247
Query: 277 ---NIPENLKRVYLELISERPNQRP------NPADFIMRN 307
+ P L ++ L+ + N RP N D ++RN
Sbjct: 248 SPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 32.3 bits (72), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 22/73 (30%), Positives = 34/73 (46%), Gaps = 7/73 (9%)
Query: 74 TFWKFHGGKKKGSNEKVTI-FLND----SADTYEPALSYVKKLKTLRHPSILTFLDSVES 128
TF K GK + + KV + LN S D ++ LK RHP I+ + +
Sbjct: 28 TFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87
Query: 129 PSKSLVYLAVEYV 141
PS +++ +EYV
Sbjct: 88 PSD--IFMVMEYV 98
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 32.0 bits (71), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 34/160 (21%), Positives = 68/160 (42%), Gaps = 14/160 (8%)
Query: 153 KENNEKKQIYISWGIF-QITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEK 211
K EK ++ +F QIT+ + + I+ L H + ++IF+ + K+G +
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDY-IHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 212 ISEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEV-------FNGPL 264
+ + +R + Y PE S D+Y LG+++ E+ F
Sbjct: 186 LKNDG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 240
Query: 265 QSTNRKSLSNIDNIPENLKRVYLELISERPNQRPNPADFI 304
T+ + D + K + +L+S++P RPN ++ +
Sbjct: 241 FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 280
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 31.6 bits (70), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 300
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 301 VYRIMTQCWQHQPEDRPNFAIILER 325
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 31.6 bits (70), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 288
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 289 VYRIMTQCWQHQPEDRPNFAIILER 313
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 31.6 bits (70), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 314
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 315 VYRIMTQCWQHQPEDRPNFAIILER 339
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 31.6 bits (70), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 280
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 281 VYRIMTQCWQHQPEDRPNFAIILER 305
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 31.6 bits (70), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 274
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 275 VYRIMTQCWQHQPEDRPNFAIILER 299
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 31.6 bits (70), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 274
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 275 VYRIMTQCWQHQPEDRPNFAIILER 299
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 31.6 bits (70), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 290
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 291 VYRIMTQCWQHQPEDRPNFAIILER 315
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 31.6 bits (70), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 232 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 291
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 292 VYRIMTQCWQHQPEDRPNFAIILER 316
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 31.6 bits (70), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 288
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 289 VYRIMTQCWQHQPEDRPNFAIILER 313
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 31.6 bits (70), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 265
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 266 VYRIMTQCWQHQPEDRPNFAIILER 290
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 31.6 bits (70), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 273
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 274 VYRIMTQCWQHQPEDRPNFAIILER 298
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 31.6 bits (70), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 273
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 274 VYRIMTQCWQHQPEDRPNFAIILER 298
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 31.6 bits (70), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 288
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 289 VYRIMTQCWQHQPEDRPNFAIILER 313
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 31.6 bits (70), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 13/85 (15%)
Query: 235 PENSLSHVTKCSTDMYGLGILIWEVFN---GPLQS-TNRKSLSNI---------DNIPEN 281
PE + + TD + G+L+WE+F+ P S +N++ L + N P
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 274
Query: 282 LKRVYLELISERPNQRPNPADFIMR 306
+ R+ + +P RPN A + R
Sbjct: 275 VYRIMTQCWQHQPEDRPNFAIILER 299
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 31.6 bits (70), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 35/159 (22%), Positives = 78/159 (49%), Gaps = 21/159 (13%)
Query: 111 LKTLRHPSILTFLDSVESPSKSL-----VYLAVEYVEPIFYHLDNTLKENNEKKQIYISW 165
+K + H +I+ L+ V +P KSL VY+ +E ++ +L ++ + +++ S+
Sbjct: 77 MKVVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDA---NLSQVIQMELDHERM--SY 130
Query: 166 GIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRY-- 223
++Q+ + L + A + H + ++I + S K+ L++ + + M Y
Sbjct: 131 LLYQMLVGIKHL-HSAGIIHRDLKPSNIVVKSDATLKI--LDFGLARTAGTSFMMTPYVV 187
Query: 224 SRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNG 262
+RY Y+ PE L K + D++ +G+++ E+ G
Sbjct: 188 TRY-----YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 31.2 bits (69), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 21/93 (22%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 169 QITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYED 228
Q+ + ++FL + + H V ++ + + K+G I S +K +R
Sbjct: 166 QVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 224
Query: 229 QSTYQIPENSLSHVTKCSTDMYGLGILIWEVFN 261
+ + PE+ V +D++ GIL+WE+F+
Sbjct: 225 K--WMAPESIFDCVYTVQSDVWSYGILLWEIFS 255
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 31.2 bits (69), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 35/159 (22%), Positives = 78/159 (49%), Gaps = 21/159 (13%)
Query: 111 LKTLRHPSILTFLDSVESPSKSL-----VYLAVEYVEPIFYHLDNTLKENNEKKQIYISW 165
+K + H +I+ L+ V +P KSL VY+ +E ++ +L ++ + +++ S+
Sbjct: 77 MKVVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDA---NLSQVIQMELDHERM--SY 130
Query: 166 GIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRY-- 223
++Q+ + L + A + H + ++I + S K+ L++ + + M Y
Sbjct: 131 LLYQMLVGIKHL-HSAGIIHRDLKPSNIVVKSDATLKI--LDFGLARTAGTSFMMTPYVV 187
Query: 224 SRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNG 262
+RY Y+ PE L K + D++ +G+++ E+ G
Sbjct: 188 TRY-----YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|2NYL|A Chain A, Crystal Structure Of Protein Phosphatase 2a (Pp2a)
Holoenzyme With The Catalytic Subunit Carboxyl Terminus
Truncated
pdb|2NYL|D Chain D, Crystal Structure Of Protein Phosphatase 2a (Pp2a)
Holoenzyme With The Catalytic Subunit Carboxyl Terminus
Truncated
pdb|2NYM|A Chain A, Crystal Structure Of Protein Phosphatase 2a (Pp2a) With
C-Terminus Truncated Catalytic Subunit
pdb|2NYM|D Chain D, Crystal Structure Of Protein Phosphatase 2a (Pp2a) With
C-Terminus Truncated Catalytic Subunit
Length = 582
Score = 31.2 bits (69), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 495 TVCVGKIAHHLHPQIRQKVLISAFSRAMRDPFPPARNAGVLALAATQQYFLLSEVAQRIL 554
+VC +++ + ++RQ F D P R A L + L V I+
Sbjct: 145 SVCYPRVSSAVKAELRQY-----FRNLCSDDTPXVRRAAASKLGEFAKVLELDNVKSEII 199
Query: 555 PALCQLSTDPEKSVRDSAFKTIKGFLGKLEQ----VSENPSLRESME 597
P L++D + SVR A + L Q P+LR++ E
Sbjct: 200 PXFSNLASDEQDSVRLLAVEACVNIAQLLPQEDLEALVXPTLRQAAE 246
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 31.2 bits (69), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 21/93 (22%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 169 QITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYED 228
Q+ + ++FL + + H V ++ + + K+G I S +K +R
Sbjct: 172 QVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 229 QSTYQIPENSLSHVTKCSTDMYGLGILIWEVFN 261
+ + PE+ V +D++ GIL+WE+F+
Sbjct: 231 K--WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 31.2 bits (69), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 21/93 (22%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 169 QITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYED 228
Q+ + ++FL + + H V ++ + + K+G I S +K +R
Sbjct: 172 QVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 229 QSTYQIPENSLSHVTKCSTDMYGLGILIWEVFN 261
+ + PE+ V +D++ GIL+WE+F+
Sbjct: 231 K--WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 31.2 bits (69), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 21/93 (22%), Positives = 42/93 (45%), Gaps = 3/93 (3%)
Query: 169 QITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYED 228
Q+ + ++FL + + H V ++ + + K+G I S +K +R
Sbjct: 168 QVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP- 225
Query: 229 QSTYQIPENSLSHVTKCSTDMYGLGILIWEVFN 261
+ PE+ V +D++ GIL+WE+F+
Sbjct: 226 -VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 30.8 bits (68), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 21/93 (22%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 169 QITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYED 228
Q+ + ++FL + + H V ++ + + K+G I S +K +R
Sbjct: 160 QVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 229 QSTYQIPENSLSHVTKCSTDMYGLGILIWEVFN 261
+ + PE+ V +D++ GIL+WE+F+
Sbjct: 219 K--WMAPESIFDCVYTVQSDVWSYGILLWEIFS 249
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 30.8 bits (68), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 21/93 (22%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 169 QITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRYED 228
Q+ + ++FL + + H V ++ + + K+G I S +K +R
Sbjct: 174 QVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 232
Query: 229 QSTYQIPENSLSHVTKCSTDMYGLGILIWEVFN 261
+ + PE+ V +D++ GIL+WE+F+
Sbjct: 233 K--WMAPESIFDCVYTVQSDVWSYGILLWEIFS 263
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 30.8 bits (68), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 42/179 (23%), Positives = 74/179 (41%), Gaps = 18/179 (10%)
Query: 111 LKTLRHPSILTFLDSVESPSKSLVYLAVEYVE--PIFYHLDNTLKENNEKKQIYISWGIF 168
LK ++HP ++ S ++ K +Y ++Y+ +FYHL + + Y +
Sbjct: 93 LKNVKHPFLVGLHFSFQTADK--LYFVLDYINGGELFYHLQRERCFLEPRARFYAA---- 146
Query: 169 QITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYM-EKISEASCIPMKRYSRYE 227
+I AL +L + ++ + + +I ++S G L E I S S +
Sbjct: 147 EIASALGYL-HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT-----STFC 200
Query: 228 DQSTYQIPENSLSHVTKCSTDMYGLGILIWEVFNG--PLQSTNRKSL-SNIDNIPENLK 283
Y PE + D + LG +++E+ G P S N + NI N P LK
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 259
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 30.4 bits (67), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 40/206 (19%), Positives = 86/206 (41%), Gaps = 32/206 (15%)
Query: 111 LKTLRHPSILTFLD--SVESPSKSLVYLAVEYVEPIFYHLDNTLKENN--EKKQIYISWG 166
+K ++HP+++ L ++E P Y+ EY+ + +L + L+E N E + + +
Sbjct: 82 MKEIKHPNLVQLLGVCTLEPP----FYIVTEYMP--YGNLLDYLRECNREEVTAVVLLYM 135
Query: 167 IFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKRYSRY 226
QI+ A+ +L + H + +C L G ++ K+++ + Y
Sbjct: 136 ATQISSAMEYL------EKKNFIHRDLAARNC----LVGENHVVKVADFGLSRLMTGDTY 185
Query: 227 EDQS------TYQIPENSLSHVTKCSTDMYGLGILIWEVFNGPLQSTNRKSLSNIDNIPE 280
+ + PE+ + +D++ G+L+WE+ + LS + ++ E
Sbjct: 186 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLE 245
Query: 281 NLKRVYLELISERPNQRPNPADFIMR 306
R+ E+P P +MR
Sbjct: 246 KGYRM------EQPEGCPPKVYELMR 265
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 30.4 bits (67), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 51/238 (21%), Positives = 94/238 (39%), Gaps = 42/238 (17%)
Query: 88 EKVTIFLNDSADTYEPALSYVKKLKTLRHPSILTFLDS-VESPSKSLVYLAVEYVEPIFY 146
+KV IF A + + LK L HP+++ + S +E ++V + +
Sbjct: 63 KKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD---- 118
Query: 147 HLDNTLKENNEKKQIY---ISWGIF-QITRALSFLINDADLRHNHVNHTSIFINSCGEWK 202
L +K ++K++ W F Q+ AL + + + H + ++FI + G K
Sbjct: 119 -LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM-HSRRVMHRDIKPANVFITATGVVK 176
Query: 203 LGGLE----YMEKISEASCIPMKRYSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWE 258
LG L + K + A + Y Y PE + +D++ LG L++E
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPY--------YMSPERIHENGYNFKSDIWSLGCLLYE 228
Query: 259 VFNGPLQSTNRKSLSNI-----------------DNIPENLKRVYLELISERPNQRPN 299
+ LQS N+ D+ E L+++ I+ P +RP+
Sbjct: 229 M--AALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPD 284
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 30.4 bits (67), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 47/239 (19%), Positives = 93/239 (38%), Gaps = 32/239 (13%)
Query: 78 FHGGKKKGSNEKVTIFLNDSADTYEPALSYVKKLKTLRHPSILTFLDSV--ESPSKSLVY 135
+ G KK S L + E L +K ++HP+++ L E P Y
Sbjct: 30 YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FY 85
Query: 136 LAVEYVEPIFYHLDNTLKENN--EKKQIYISWGIFQITRALSFLINDADLRHNHVNHTSI 193
+ +E++ + +L + L+E N E + + + QI+ A+ +L + H +
Sbjct: 86 IIIEFM--TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL------EKKNFIHRDL 137
Query: 194 FINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQS------TYQIPENSLSHVTKCST 247
+C L G ++ K+++ + Y + + PE+ + +
Sbjct: 138 AARNC----LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 248 DMYGLGILIWEVFNGPLQSTNRKSLSNIDNIPENLKRVYLELISERPNQRPNPADFIMR 306
D++ G+L+WE+ + LS + + E R+ ERP P +MR
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------ERPEGCPEKVYELMR 246
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 30.4 bits (67), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 47/239 (19%), Positives = 93/239 (38%), Gaps = 32/239 (13%)
Query: 78 FHGGKKKGSNEKVTIFLNDSADTYEPALSYVKKLKTLRHPSILTFLDSV--ESPSKSLVY 135
+ G KK S L + E L +K ++HP+++ L E P Y
Sbjct: 30 YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FY 85
Query: 136 LAVEYVEPIFYHLDNTLKENN--EKKQIYISWGIFQITRALSFLINDADLRHNHVNHTSI 193
+ +E++ + +L + L+E N E + + + QI+ A+ +L + H +
Sbjct: 86 IIIEFM--TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL------EKKNFIHRDL 137
Query: 194 FINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQS------TYQIPENSLSHVTKCST 247
+C L G ++ K+++ + Y + + PE+ + +
Sbjct: 138 AARNC----LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 248 DMYGLGILIWEVFNGPLQSTNRKSLSNIDNIPENLKRVYLELISERPNQRPNPADFIMR 306
D++ G+L+WE+ + LS + + E R+ ERP P +MR
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------ERPEGCPEKVYELMR 246
>pdb|3FGA|A Chain A, Structural Basis Of Pp2a And Sgo Interaction
Length = 588
Score = 30.4 bits (67), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 495 TVCVGKIAHHLHPQIRQKVLISAFSRAMRDPFPPARNAGVLALAATQQYFLLSEVAQRIL 554
+VC +++ + ++RQ F D P R A L + L V I+
Sbjct: 151 SVCYPRVSSAVKAELRQY-----FRNLCSDDTPMVRRAAASKLGEFAKVLELDNVKSEII 205
Query: 555 PALCQLSTDPEKSVRDSAFKTIKGFLGKLEQ----VSENPSLRESME 597
P L++D + SVR A + L Q P+LR++ E
Sbjct: 206 PMFSNLASDEQDSVRLLAVEACVNIAQLLPQEDLEALVMPTLRQAAE 252
>pdb|2IE3|A Chain A, Structure Of The Protein Phosphatase 2a Core Enzyme Bound
To Tumor- Inducing Toxins
pdb|2IE4|A Chain A, Structure Of The Protein Phosphatase 2a Core Enzyme Bound
To Okadaic Acid
pdb|2NPP|A Chain A, Structure Of The Protein Phosphatase 2a Holoenzyme
pdb|2NPP|D Chain D, Structure Of The Protein Phosphatase 2a Holoenzyme
pdb|3K7V|A Chain A, Protein Phosphatase 2a Core Complex Bound To
Dinophysistoxin-1
pdb|3K7W|A Chain A, Protein Phosphatase 2a Core Complex Bound To
Dinophysistoxin-2
Length = 589
Score = 30.4 bits (67), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 495 TVCVGKIAHHLHPQIRQKVLISAFSRAMRDPFPPARNAGVLALAATQQYFLLSEVAQRIL 554
+VC +++ + ++RQ F D P R A L + L V I+
Sbjct: 152 SVCYPRVSSAVKAELRQY-----FRNLCSDDTPMVRRAAASKLGEFAKVLELDNVKSEII 206
Query: 555 PALCQLSTDPEKSVRDSAFKTIKGFLGKLEQ----VSENPSLRESME 597
P L++D + SVR A + L Q P+LR++ E
Sbjct: 207 PMFSNLASDEQDSVRLLAVEACVNIAQLLPQEDLEALVMPTLRQAAE 253
>pdb|1B3U|A Chain A, Crystal Structure Of Constant Regulatory Domain Of Human
Pp2a, Pr65alpha
pdb|1B3U|B Chain B, Crystal Structure Of Constant Regulatory Domain Of Human
Pp2a, Pr65alpha
Length = 588
Score = 30.4 bits (67), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 495 TVCVGKIAHHLHPQIRQKVLISAFSRAMRDPFPPARNAGVLALAATQQYFLLSEVAQRIL 554
+VC +++ + ++RQ F D P R A L + L V I+
Sbjct: 151 SVCYPRVSSAVKAELRQY-----FRNLCSDDTPMVRRAAASKLGEFAKVLELDNVKSEII 205
Query: 555 PALCQLSTDPEKSVRDSAFKTIKGFLGKLEQ----VSENPSLRESME 597
P L++D + SVR A + L Q P+LR++ E
Sbjct: 206 PMFSNLASDEQDSVRLLAVEACVNIAQLLPQEDLEALVMPTLRQAAE 252
>pdb|2IAE|A Chain A, Crystal Structure Of A Protein Phosphatase 2a (Pp2a)
Holoenzyme.
pdb|2IAE|D Chain D, Crystal Structure Of A Protein Phosphatase 2a (Pp2a)
Holoenzyme.
pdb|2PF4|A Chain A, Crystal Structure Of The Full-Length Simian Virus 40 Small
T Antigen Complexed With The Protein Phosphatase 2a
Aalpha Subunit
pdb|2PF4|B Chain B, Crystal Structure Of The Full-Length Simian Virus 40 Small
T Antigen Complexed With The Protein Phosphatase 2a
Aalpha Subunit
pdb|2PF4|C Chain C, Crystal Structure Of The Full-Length Simian Virus 40 Small
T Antigen Complexed With The Protein Phosphatase 2a
Aalpha Subunit
pdb|2PF4|D Chain D, Crystal Structure Of The Full-Length Simian Virus 40 Small
T Antigen Complexed With The Protein Phosphatase 2a
Aalpha Subunit
Length = 589
Score = 30.0 bits (66), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 495 TVCVGKIAHHLHPQIRQKVLISAFSRAMRDPFPPARNAGVLALAATQQYFLLSEVAQRIL 554
+VC +++ + ++RQ F D P R A L + L V I+
Sbjct: 152 SVCYPRVSSAVKAELRQY-----FRNLCSDDTPMVRRAAASKLGEFAKVLELDNVKSEII 206
Query: 555 PALCQLSTDPEKSVRDSAFKTIKGFLGKLEQ----VSENPSLRESME 597
P L++D + SVR A + L Q P+LR++ E
Sbjct: 207 PMFSNLASDEQDSVRLLAVEACVNIAQLLPQEDLEALVMPTLRQAAE 253
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 30.0 bits (66), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 47/239 (19%), Positives = 93/239 (38%), Gaps = 32/239 (13%)
Query: 78 FHGGKKKGSNEKVTIFLNDSADTYEPALSYVKKLKTLRHPSILTFLDSV--ESPSKSLVY 135
+ G KK S L + E L +K ++HP+++ L E P Y
Sbjct: 35 YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FY 90
Query: 136 LAVEYVEPIFYHLDNTLKENN--EKKQIYISWGIFQITRALSFLINDADLRHNHVNHTSI 193
+ +E++ + +L + L+E N E + + + QI+ A+ +L + H +
Sbjct: 91 IIIEFM--TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL------EKKNFIHRDL 142
Query: 194 FINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQS------TYQIPENSLSHVTKCST 247
+C L G ++ K+++ + Y + + PE+ + +
Sbjct: 143 AARNC----LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 248 DMYGLGILIWEVFNGPLQSTNRKSLSNIDNIPENLKRVYLELISERPNQRPNPADFIMR 306
D++ G+L+WE+ + LS + + E R+ ERP P +MR
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------ERPEGCPEKVYELMR 251
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 30.0 bits (66), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 18/65 (27%), Positives = 30/65 (46%), Gaps = 13/65 (20%)
Query: 247 TDMYGLGILIWEVFN-GPLQSTNRKSLSNIDNIPENLKRVYLELIS------------ER 293
+D++ G+L+WEVF+ G + NR + +++I + L S ER
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKER 244
Query: 294 PNQRP 298
P RP
Sbjct: 245 PEDRP 249
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 30.0 bits (66), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 20/80 (25%), Positives = 33/80 (41%), Gaps = 13/80 (16%)
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFN---GPLQSTNRKS----------LSNIDNI 278
+ PE+ V S+DM+ G+++WE+ + P Q + + L DN
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 279 PENLKRVYLELISERPNQRP 298
PE + + PN RP
Sbjct: 258 PERVTDLMRMCWQFNPNMRP 277
>pdb|3DW8|A Chain A, Structure Of A Protein Phosphatase 2a Holoenzyme With B55
Subunit
pdb|3DW8|D Chain D, Structure Of A Protein Phosphatase 2a Holoenzyme With B55
Subunit
Length = 582
Score = 30.0 bits (66), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 495 TVCVGKIAHHLHPQIRQKVLISAFSRAMRDPFPPARNAGVLALAATQQYFLLSEVAQRIL 554
+VC +++ + ++RQ F D P R A L + L V I+
Sbjct: 145 SVCYPRVSSAVKAELRQY-----FRNLCSDDTPMVRRAAASKLGEFAKVLELDNVKSEII 199
Query: 555 PALCQLSTDPEKSVRDSAFKTIKGFLGKLEQ----VSENPSLRESME 597
P L++D + SVR A + L Q P+LR++ E
Sbjct: 200 PMFSNLASDEQDSVRLLAVEACVNIAQLLPQEDLEALVMPTLRQAAE 246
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 30.0 bits (66), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 18/65 (27%), Positives = 30/65 (46%), Gaps = 13/65 (20%)
Query: 247 TDMYGLGILIWEVFN-GPLQSTNRKSLSNIDNIPENLKRVYLELIS------------ER 293
+D++ G+L+WEVF+ G + NR + +++I + L S ER
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRER 247
Query: 294 PNQRP 298
P RP
Sbjct: 248 PEDRP 252
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 30.0 bits (66), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 18/65 (27%), Positives = 30/65 (46%), Gaps = 13/65 (20%)
Query: 247 TDMYGLGILIWEVFN-GPLQSTNRKSLSNIDNIPENLKRVYLELIS------------ER 293
+D++ G+L+WEVF+ G + NR + +++I + L S ER
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKER 244
Query: 294 PNQRP 298
P RP
Sbjct: 245 PEDRP 249
>pdb|2PKG|A Chain A, Structure Of A Complex Between The A Subunit Of Protein
Phosphatase 2a And The Small T Antigen Of Sv40
pdb|2PKG|B Chain B, Structure Of A Complex Between The A Subunit Of Protein
Phosphatase 2a And The Small T Antigen Of Sv40
Length = 580
Score = 30.0 bits (66), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 9/107 (8%)
Query: 495 TVCVGKIAHHLHPQIRQKVLISAFSRAMRDPFPPARNAGVLALAATQQYFLLSEVAQRIL 554
+VC +++ + ++RQ F D P R A L + L V I+
Sbjct: 143 SVCYPRVSSAVKAELRQY-----FRNLCSDDTPMVRRAAASKLGEFAKVLELDNVKSEII 197
Query: 555 PALCQLSTDPEKSVRDSAFKTIKGFLGKLEQ----VSENPSLRESME 597
P L++D + SVR A + L Q P+LR++ E
Sbjct: 198 PMFSNLASDEQDSVRLLAVEACVNIAQLLPQEDLEALVMPTLRQAAE 244
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 30.0 bits (66), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 20/80 (25%), Positives = 33/80 (41%), Gaps = 13/80 (16%)
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFN---GPLQSTNRKS----------LSNIDNI 278
+ PE+ V S+DM+ G+++WE+ + P Q + + L DN
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 257
Query: 279 PENLKRVYLELISERPNQRP 298
PE + + PN RP
Sbjct: 258 PERVTDLMRMCWQFNPNMRP 277
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 30.0 bits (66), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 20/80 (25%), Positives = 33/80 (41%), Gaps = 13/80 (16%)
Query: 232 YQIPENSLSHVTKCSTDMYGLGILIWEVFN---GPLQSTNRKS----------LSNIDNI 278
+ PE+ V S+DM+ G+++WE+ + P Q + + L DN
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNC 258
Query: 279 PENLKRVYLELISERPNQRP 298
PE + + PN RP
Sbjct: 259 PERVTDLMRMCWQFNPNMRP 278
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 30.0 bits (66), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 18/65 (27%), Positives = 30/65 (46%), Gaps = 13/65 (20%)
Query: 247 TDMYGLGILIWEVFN-GPLQSTNRKSLSNIDNIPENLKRVYLELIS------------ER 293
+D++ G+L+WEVF+ G + NR + +++I + L S ER
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKER 242
Query: 294 PNQRP 298
P RP
Sbjct: 243 PEDRP 247
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 30.0 bits (66), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 18/65 (27%), Positives = 30/65 (46%), Gaps = 13/65 (20%)
Query: 247 TDMYGLGILIWEVFN-GPLQSTNRKSLSNIDNIPENLKRVYLELIS------------ER 293
+D++ G+L+WEVF+ G + NR + +++I + L S ER
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRER 245
Query: 294 PNQRP 298
P RP
Sbjct: 246 PEDRP 250
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 30.0 bits (66), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 18/65 (27%), Positives = 30/65 (46%), Gaps = 13/65 (20%)
Query: 247 TDMYGLGILIWEVFN-GPLQSTNRKSLSNIDNIPENLKRVYLELIS------------ER 293
+D++ G+L+WEVF+ G + NR + +++I + L S ER
Sbjct: 205 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKER 264
Query: 294 PNQRP 298
P RP
Sbjct: 265 PEDRP 269
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 30.0 bits (66), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 36/115 (31%), Positives = 51/115 (44%), Gaps = 10/115 (8%)
Query: 111 LKTLRHPSILTFLDSVES--PSKSLVYLAVEYVEPIFYHLDNTLKE-NNEKKQIYISWGI 167
LK L+HP+I+ F DS ES K + L E L LK K ++ SW
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTS--GTLKTYLKRFKVXKIKVLRSW-C 135
Query: 168 FQITRALSFL-INDADLRHNHVNHTSIFINS-CGEWKLG--GLEYMEKISEASCI 218
QI + L FL + H + +IFI G K+G GL +++ S A +
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV 190
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 29.6 bits (65), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 17/157 (10%)
Query: 104 ALSYVKKLKTLRHPSILTFLDSVESPSKSLVYLAVEYVEPIFYHLDNTLKENN-EKKQIY 162
AL +K L+ L HP+I+ LD+ KS + L +++E L+ +K+N+ +
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFG--HKSNISLVFDFME---TDLEVIIKDNSLVLTPSH 113
Query: 163 ISWGIFQITRALSFLINDADLRHNHVNHTSIFINSCGEWKLGGLEYMEKISEASCIPMKR 222
I + + L +L + + H + ++ ++ G KL ++++ P +
Sbjct: 114 IKAYMLMTLQGLEYL-HQHWILHRDLKPNNLLLDENGVLKLADF----GLAKSFGSPNRA 168
Query: 223 YSRYEDQSTYQIPENSLSHVTKCSTDMYGLGILIWEV 259
Y Y+ PE MYG+G+ +W V
Sbjct: 169 YXHQVVTRWYRAPELLF------GARMYGVGVDMWAV 199
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 29.3 bits (64), Expect = 8.7, Method: Compositional matrix adjust.
Identities = 42/213 (19%), Positives = 86/213 (40%), Gaps = 31/213 (14%)
Query: 66 SGCFTQKHTFWKFHGGK---KKGSNEKVTIFLNDSADTYEPALSYVKKLKTLRHPSILTF 122
+G F + H H G+ K +++ + L T + L L + HP I+
Sbjct: 16 TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM----LSIVTHPFIIRM 71
Query: 123 LDSVESPSKSLVYLAVEYVE--PIFYHLDNTLKENNEKKQIYISWGIFQITRALSFLIND 180
+ + + +++ ++Y+E +F L + + N + Y + ++ AL +L +
Sbjct: 72 WGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA----EVCLALEYL-HS 124
Query: 181 ADLRHNHVNHTSIFINSCGEWKL---GGLEYMEKISEASCIPMKRYSRYEDQSTYQIPEN 237
D+ + + +I ++ G K+ G +Y+ ++ C Y PE
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC----------GTPDYIAPEV 174
Query: 238 SLSHVTKCSTDMYGLGILIWEVFNG--PLQSTN 268
+ S D + GILI+E+ G P +N
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 29.3 bits (64), Expect = 9.5, Method: Compositional matrix adjust.
Identities = 47/239 (19%), Positives = 92/239 (38%), Gaps = 32/239 (13%)
Query: 78 FHGGKKKGSNEKVTIFLNDSADTYEPALSYVKKLKTLRHPSILTFLDSV--ESPSKSLVY 135
+ G KK S L + E L +K ++HP+++ L E P Y
Sbjct: 35 YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FY 90
Query: 136 LAVEYVEPIFYHLDNTLKENN--EKKQIYISWGIFQITRALSFLINDADLRHNHVNHTSI 193
+ E++ + +L + L+E N E + + + QI+ A+ +L + H +
Sbjct: 91 IITEFM--TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL------EKKNFIHRDL 142
Query: 194 FINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQS------TYQIPENSLSHVTKCST 247
+C L G ++ K+++ + Y + + PE+ + +
Sbjct: 143 AARNC----LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 248 DMYGLGILIWEVFNGPLQSTNRKSLSNIDNIPENLKRVYLELISERPNQRPNPADFIMR 306
D++ G+L+WE+ + LS + + E R+ ERP P +MR
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------ERPEGCPEKVYELMR 251
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 29.3 bits (64), Expect = 9.8, Method: Compositional matrix adjust.
Identities = 47/239 (19%), Positives = 92/239 (38%), Gaps = 32/239 (13%)
Query: 78 FHGGKKKGSNEKVTIFLNDSADTYEPALSYVKKLKTLRHPSILTFLDSV--ESPSKSLVY 135
+ G KK S L + E L +K ++HP+++ L E P Y
Sbjct: 35 YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP----FY 90
Query: 136 LAVEYVEPIFYHLDNTLKENN--EKKQIYISWGIFQITRALSFLINDADLRHNHVNHTSI 193
+ E++ + +L + L+E N E + + + QI+ A+ +L + H +
Sbjct: 91 IITEFM--TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL------EKKNFIHRDL 142
Query: 194 FINSCGEWKLGGLEYMEKISEASCIPMKRYSRYEDQS------TYQIPENSLSHVTKCST 247
+C L G ++ K+++ + Y + + PE+ + +
Sbjct: 143 AARNC----LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 248 DMYGLGILIWEVFNGPLQSTNRKSLSNIDNIPENLKRVYLELISERPNQRPNPADFIMR 306
D++ G+L+WE+ + LS + + E R+ ERP P +MR
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------ERPEGCPEKVYELMR 251
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.316 0.132 0.387
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 21,295,996
Number of Sequences: 62578
Number of extensions: 802084
Number of successful extensions: 2418
Number of sequences better than 100.0: 173
Number of HSP's better than 100.0 without gapping: 3
Number of HSP's successfully gapped in prelim test: 170
Number of HSP's that attempted gapping in prelim test: 2380
Number of HSP's gapped (non-prelim): 188
length of query: 852
length of database: 14,973,337
effective HSP length: 107
effective length of query: 745
effective length of database: 8,277,491
effective search space: 6166730795
effective search space used: 6166730795
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 56 (26.2 bits)